Rotigotine
Code | Size | Price |
---|
TAR-T9237-5mg | 5mg | £109.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T9237-1mL | 1 mL * 10 mM (in DMSO) | £120.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T9237-10mg | 10mg | £127.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T9237-25mg | 25mg | £161.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T9237-50mg | 50mg | £205.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T9237-100mg | 100mg | £270.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Rotigotine is an antiparkinson agent and dopamine receptor agonist.
CAS:
92206-54-7
Formula:
C19H25NOS
Molecular Weight:
315.47
Pathway:
GPCR/G Protein; Neuroscience
Purity:
0.98
SMILES:
CCCN(CCc1cccs1)C(CC1)Cc2c1c(O)ccc2
Target:
Dopamine Receptor
References
Frampton J E . Rotigotine Transdermal Patch: A Review in Parkinson's Disease[J]. CNS Drugs, 2019, 33(2):1-12.
Kang H, Yu H, Fan J, et al. Rotigotine protects against oxidized low-density lipoprotein (ox-LDL)-induced damages in human umbilical vein endothelial cells (HUVECs). Bioengineered. 2021, 12(2): 10568-10579.
Chen F , Jin L , Nie Z . Safety and Efficacy of Rotigotine for Treating Parkinson's Disease: A Meta-Analysis of Randomised Controlled Trials[J]. Journal of Pharmacy & Pharmaceutical Sciences, 2017, 20:285-.